Show simple item record

dc.contributor.authorBoff, Evertonpt_BR
dc.contributor.authorLopes, Paulo Guilherme Markuspt_BR
dc.contributor.authorSpader, Tatiana Borbapt_BR
dc.contributor.authorScheid, Liliane Alvespt_BR
dc.contributor.authorLoreto, Éricopt_BR
dc.contributor.authorDal Formo, Nara Frassonpt_BR
dc.contributor.authorAquino, Valério Rodriguespt_BR
dc.contributor.authorSantúrio, Jânio Moraispt_BR
dc.contributor.authorSevero, Luiz Carlospt_BR
dc.contributor.authorAlves, Sydney Hartzpt_BR
dc.date.accessioned2010-05-12T04:16:50Zpt_BR
dc.date.issued2008pt_BR
dc.identifier.issn0037-8682pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/21908pt_BR
dc.description.abstractComparou-se a suscetibilidade à anfotericina B de Candida spp isoladas de candidemias, sendo: 41 do Hospital Universitário de Santa Maria, 56 do Hospital de Clínicas de Porto Alegre e 47 da Santa Casa, Complexo Hospitalar de Porto Alegre. Os testes foram baseados no documento M27-A2 do Clinical Laboratory Standards Institute. Todavia, foram empregadas 20 concentrações de anfotericina B, variáveis entre 0,1 e 2μg/ml. Os testes foram realizados nos meios RPMI 1640 com glicose, antibiotic medium 3 e yeast nitrogen base dextrosado. O caldo antibiotic medium 3 gerou amplas faixas de concentrações inibitórias mínimas e concentrações fungicidas mínimas quando comparado aos demais. As variações de suscetibilidade entre os hospitais foram melhor detectadas no antibiotic médium 3; os isolados do Hospital Universitário de Santa Maria evidenciaram menor sensibilidade do que os da Santa Casa, Complexo Hospitalar de Porto Alegre (p < 0,05). As causas das variações de suscetibilidade não foram avaliadas mas apontam para a necessidade de vigilância da suscetibilidade a anfotericina B.pt_BR
dc.description.abstractSusceptibility to amphotericin B was compared between isolates of Candida spp that were obtained from candidemia cases as follows: 41 from Hospital Universitário de Santa Maria, 56 from Hospital de Clínicas, Porto Alegre, and 47 from the Santa Casa hospital complex, Porto Alegre. The tests were based on the document M27-A2 from the Clinical Laboratory Standards Institute, but with 20 concentrations of amphotericin B ranging from 0.1 to 2µg/ml. The tests were carried out using RPMI 1640 medium with glucose, antibiotic medium 3 and yeast nitrogen base-dextrose. The antibiotic medium 3 broth generated wide ranges of minimum inhibitory concentrations and minimum fungicidal concentrations in relation to the other agents. The variations in susceptibility between the hospitals were best detected in antibiotic medium 3. The isolates from Hospital Universitário de Santa Maria showed lower susceptibility than did those from the Santa Casa hospital complex, Porto Alegre (p < 0.05). The causes of the susceptibility variations were not assessed but they indicate the need for surveillance regarding the susceptibility to amphotericin B.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoporpt_BR
dc.relation.ispartofRevista da Sociedade Brasileira de Medicina Tropical. Brasília. Vol. 41, n. 1 (jan./fev. 2008), p. 36-40pt_BR
dc.rightsOpen Accessen
dc.subjectSuscetibilidade a doençaspt_BR
dc.subjectSusceptibilityen
dc.subjectAmphotericin Ben
dc.subjectAnfotericina Bpt_BR
dc.subjectCandidapt_BR
dc.subjectCandidaen
dc.subjectHospitaispt_BR
dc.subjectCandidemiaen
dc.titleReavaliação da suscetibilidade de candida a anfotericina B : estudo comparativo com isolados de três hospitais do estado do Rio Grande do Sulpt_BR
dc.title.alternativeRe-evaluation of candida susceptibility to amphotericin B: comparative study with isolates from three hospitals of the Rio Grande do Sul state en
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb000637488pt_BR
dc.type.originNacionalpt_BR


Files in this item

Thumbnail
   

This item is licensed under a Creative Commons License

Show simple item record